Example: Heart Attack

Search clinical trials for: Formoterol

Total 478 results

NCT04494321

Completed

A Bioequivalence Pivotal Study of SYN010 HFA Inhaler and Symbicort® 160/4.5 in Healthy Volunteers Without Charcoal Block

Conditions: Asthma; COPD
NCT04480242

Recruiting

Asthma Research in Children and Adolescents

Conditions: Persistent Asthma; Asthma in Children; Asthma Exacerbation
NCT04421742

Completed

The Effect of Beclomethasone/Formoterol in Extra-fine Formulation on Quality of Life and SAD in COPD Patients.

Conditions: Chronic Obstructive Pulmonary Disease
NCT04331054

Recruiting

Protective Role of Inhaled Steroids for Covid-19 Infection

Conditions: Covid-19 Infection; Hospitalization in Respiratory Disease Department
NCT04331470

Recruiting

Evaluation of Efficacy of Levamisole and Formoterol+Budesonide in Treatment of COVID-19

Conditions: COVID-19
NCT04320342

Not yet recruiting

A Phase III Study Comparing Efficacy, Safety and Tolerability of the Fixed Dose Triple Combination CHF 5993 With the Fixed Dose Dual Combination CHF 1535 in Subjects With COPD

Conditions: COPD; COPD Exacerbation
NCT04271839

Withdrawn

Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

Conditions: Persistent Asthma
NCT04233190

Not yet recruiting

A Multicenter, Randomized, Parallel, Open, Two-period, Comparative Non-inferiority Clinical Trial of Eurofarma Versus Alenia® in the Treatment of Moderate to Severe

Conditions: Asthma Copd
NCT04215848

Recruiting

As-needed Budesonide/Formoterol Turbuhaler in Stepping Down Period

Conditions: Asthma
NCT04208581

Enrolling by invitation

Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure

Conditions: Chronic Obstructive Pulmonary Disease; Chronic Respiratory Failure
NCT04203472

Recruiting

Optimal Type of Inhaler in Cough Variant- or Cough Predominant Asthma

Conditions: Asthma; Cough Variant Asthma
NCT04193878

Recruiting

ARrest RESpiraTory Failure From PNEUMONIA

Conditions: Pneumonia; Hypoxemia; Acute Respiratory Failure; COVID-19
NCT04191434

Not yet recruiting

Efficacy and Safety of Flamboyant 125/12 Association in the Treatment of Adults With Moderate Asthma

Conditions: Asthma
NCT04191447

Not yet recruiting

Efficacy and Safety of Flamboyant 200/12 Association in the Treatment of Adults With Severe Asthma

Conditions: Asthma
NCT04179461

Completed

Personalized Treatment Algorithms for Difficult-to-treat Asthma

Conditions: Asthma in Children
NCT04171180

Recruiting

The Efficacy of Budesonide/Formoterol in Cough Variant Asthma

Conditions: Cough Variant Asthma
NCT04159519

Not yet recruiting

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

Conditions: Asthma; Severe Eosinophilic Asthma
NCT04137029

Recruiting

Methacholine, Long-acting M-cholinolytic and beta2-agonist on the Activity of Beta-receptors in Healthy Volunteers

Conditions: Health, Subjective; Hyperreactivity, Bronchial
NCT04124510

Not yet recruiting

Efficacy and Safety of Flutiform K-haler in Patients With Uncontrolled Asthma Following Mid-dose ICS/LABA DPI Therapy

Conditions: Asthma
NCT04087590

Not yet recruiting

Impact of Inhaled PT003 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient

Conditions: Copd
NCT04083066

Recruiting

Open Randomized Prospective Clinical Study of R-FPD Versus R-MAD Regimen in the Treatment of Primary Central Nervous System Lymphoma

Conditions: Primary Central Nervous System Lymphoma
NCT04078126

Suspended

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT03963167

Recruiting

Triple Therapy in Real-life: Impact on Adherence and Health Status (TRITRIAL)

Conditions: COPD
NCT03924635

Active, not recruiting

An Exploratory Study to Characterise Changes in Airway Inflammation, Symptoms, Lung Function and Reliever Use in Adult Asthma Patients

Conditions: Airway Inflammation; Asthma
NCT03906045

Completed

A Scintigraphy Study of PT010 in COPD Patients

Conditions: Chronic Obstructive Pulmonary Disease
NCT03888131

Recruiting

Foster® pMDI (CHF 1535) Versus Symbicort® Turbohaler in COPD Patient

Conditions: Chronic Obstructive Pulmonary Disease
NCT03846570

Recruiting

Formoterol-beclomethasone in Patients With Bronchiectasis: a Randomized Controlled Trial

Conditions: Bronchiectasis
NCT03842904

Completed

A Study Comparing the Effects of Trimbow to Fostair in COPD

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT03836677

Completed

A Study to Evaluate the Effects of BGF and GFF on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT03795350

Terminated

Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients

Conditions: Chronic Obstructive Pulmonary Disease; Asthma
NCT03788395

Completed

The Use of an Innovative Device for Therapeutic Adherence in Pediatric Asthma

Conditions: Asthma
NCT03740373

Completed

A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate

Conditions: Pulmonary Disease, Chronic Obstructive
NCT03691961

Recruiting

Corticosteroids/β2-agonists in Hair in Asthmatic Patients (CorticHair)

Conditions: Asthma
NCT03662711

Recruiting

Inhaled Long-acting Bronchodilators With or Without Inhaled Glucocorticosteroids for Preventing Hospitalizations and Death in Elderly Patients With Chronic Obstructive Pulmonary Disease

Conditions: Pulmonary Disease, Chronic Obstructive
NCT03627858

Active, not recruiting

Fixed Dose Triple Therapy in Severe Chronic Obstructive Pulmonary Disease in a Real World Setting

Conditions: Chronic Obstructive Pulmonary Disease
NCT03590379

Completed

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Chronic Obstructive Pulmonary Disease
NCT03573817

Completed

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT03565302

Recruiting

Beta2-adrenergic Agonism and Muscle Remodelling

Conditions: Hypertrophy; Physiologic Hypertrophy; Physical Activity
NCT03563001

Unknown status

Differences of Small Airways Function Between Chronic Obstructive Pulmonary Disease(COPD) and Asthma-copd Overlap(ACO)

Conditions: Pulmonary Disease, Chronic Obstructive; Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome; Small Airway Disease; Quality of Life
NCT03551197

Unknown status

Change of Lung Function After Exercise in Patients With Chronic Obstructive Pulmonary Disease

Conditions: Pulmonary Disease, Chronic Obstructive; Exercise; Lung Function Decreased; Quality of Life
NCT03504527

Unknown status

Efficiency of Budesonide Combined With Formoterol and Tiotropium in the Treatment of Acute Exacerbation of ACO

Conditions: Asthma-COPD Overlap
NCT03478683

Completed

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Pulmonary Disease, Chronic Obstructive
NCT03478696

Completed

A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Conditions: Pulmonary Disease, Chronic Obstructive
NCT03468790

Enrolling by invitation

Anti-IgE Monoclonal Antibody Treatment in Patients With Allergic Asthma.

Conditions: Asthma, Allergic
NCT03453112

Recruiting

Foster 100/6 mg NEXThaler Versus Foster 100/6mg Pressurized Metered-dose Inhaler (pMDI) in Patients With Controlled Asthma.

Conditions: Asthma
NCT03387241

Recruiting

Efficacy of FLUTIFORM ® vs Seretide® in Moderate to Severe Persistent Asthma in Subjects Aged ≥12 Years

Conditions: Asthma
NCT03333018

Completed

A Drug Utilisation Post-authorisation Study of New Users of Aclidinium Bromide (Monotherapy or in Combination)

Conditions: Pulmonary Disease, Chronic Obstructive
NCT03324607

Completed

Effects of Bevespi on Ventilation and Gas Exchange Abnormalities in COPD Assessed by 129Xe MRI

Conditions: Copd
NCT03319043

Unknown status

Observation of Cough Variant Asthma Treated in Combination of Chanqin Granules.

Conditions: Cough Variant Asthma
NCT03290287

Recruiting

Aclidinium Bromide Post-Authorisation Safety Study to Evaluate the Risk of Cardiovascular Endpoints

Conditions: Pulmonary Disease, Chronic Obstructive

Search clinical trials for: Formoterol

Recent CRA jobs

Medical Comm Writer 1

Applications Administrator(SAS Grid)

Associate Project Manager - GOV

Associate CTM

Assoc Scientist- CSD

Pharmacovigilance Manager

Lab Supervisor - Client dedicated

Scientist, Cell and Gene Therapy – (on-site Stevenage, UK - 18 month contract)

Senior Scientist - Biopharmaceutical Stability Testing

Associate Scientist - PCC